MENU
+Compare
NUWE
Stock ticker: NASDAQ
AS OF
Sep 17, 04:57 PM (EDT)
Price
$3.95
Change
-$0.18 (-4.36%)
Capitalization
3.73M

NUWE Nuwellis Inc Forecast, Technical & Fundamental Analysis

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems... Show more

NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUWE with price predictions
Sep 16, 2025

Momentum Indicator for NUWE turns negative, indicating new downward trend

NUWE saw its Momentum Indicator move below the 0 level on August 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In of the 90 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUWE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NUWE entered a downward trend on September 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NUWE's RSI Oscillator exited the oversold zone, of 56 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 74 cases where NUWE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUWE just turned positive on August 18, 2025. Looking at past instances where NUWE's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

NUWE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.256) is normal, around the industry mean (60.170). P/E Ratio (0.009) is within average values for comparable stocks, (38.085). NUWE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.614). NUWE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.033) is also within normal values, averaging (128.106).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NUWE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUWE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of heart assist devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
12988 Valley View Road
Phone
+1 952 345-4200
Employees
59
Web
https://www.nuwellis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOW5.180.02
+0.39%
WideOpenWest
MAYS38.00N/A
N/A
J. W. Mays
WT13.86-0.04
-0.29%
WisdomTree
GL140.86-1.57
-1.10%
Globe Life
NDRA4.78-0.09
-1.85%
ENDRA Life Sciences Inc

NUWE and Stocks

Correlation & Price change

A.I.dvisor tells us that NUWE and CORBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-12.13%
CORBF - NUWE
24%
Poorly correlated
N/A
PRE - NUWE
24%
Poorly correlated
-2.97%
BNR - NUWE
23%
Poorly correlated
-2.53%
HSDT - NUWE
23%
Poorly correlated
+22.22%
VTAK - NUWE
22%
Poorly correlated
-1.19%
More

Groups containing NUWE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-12.13%
Medical/Nursing Services
industry (225 stocks)
14%
Poorly correlated
-0.72%
Health Services
industry (437 stocks)
12%
Poorly correlated
-0.40%